12:00 AM
 | 
Apr 10, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

Antibody-based ImmunoTherapy regulatory update

AXO received Australian Patent No. 711,270 covering a method of treating cancer with an...

Read the full 46 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >